In Re: National Prescription Opiate Litigation

Track this case

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

April 20, 2022
Endo Reaches $10M Deal With SF Ahead Of Opioid Trial

Endo Pharmaceuticals has agreed to pay $10 million over the course of 10 years to resolve the city of San Francisco's claims stemming from the drugmaker's role in the opioid crisis, a deal that comes just days before the company's bellwether bench trial was set to kick off in California federal court, according to an announcement Wednesday.
April 12, 2022
Mapping The Top Trials To Know In The Opioid Litigation Wave

Opioid crisis lawsuits against major companies in the pharmaceutical supply chain are heating up in large numbers, producing a byzantine brew of battles in courts all across America. Here, Law360 provides a map that will continue to track completed, ongoing and upcoming trials.
April 09, 2022
In Surprise Move, Panel Stops Adding Cases To Opioid MDL

The Judicial Panel on Multidistrict Litigation unexpectedly ruled late Friday that a huge and historic MDL for opioid crisis lawsuits against pharmaceutical companies has accomplished key objectives and doesn't offer enough remaining upsides to warrant the addition of future cases.
April 08, 2022
Big Pharma Can't Beat SF Opioid Claims Before Trial

Teva Pharmaceuticals, Allergan, Anda Inc. and other drugmakers and distributors can't escape San Francisco's claims in an upcoming bellwether bench trial, the California federal judge overseeing the multidistrict opioid litigation has ruled, but Endo International can beat allegations attributed to its subsidiaries.
April 05, 2022
'Intense Pressure' To Ink Opioid Deal? Too Bad, 6th Circ. Says

The Sixth Circuit on Tuesday swatted away protests from Walgreens and Walmart about "extraordinary, unusual pressure" to strike a settlement after a jury blamed them for out-of-control opioid sales, clearing the way for the first damages trial against pharmacy giants in multidistrict litigation.
April 04, 2022
Opioid MDL Judge Cites Miss Piggy To Explain Time Limits

The California federal judge overseeing an upcoming bellwether bench trial in multidistrict opioid litigation explained the strict time limits he put on the trial's testimony Monday, declaring that like Miss Piggy, "Opioid trial, c'est moi."
March 23, 2022
Opioid MDL Bellwether In SF Gets 'Shocking' Cut To Trial Time

An impending bellwether trial involving San Francisco and several drug companies in multidistrict opioid litigation will be among the shortest opioid trials yet despite shaping up as one of the largest, a California federal judge said Wednesday, an admittedly startling move accompanied by other streamlining efforts.
March 22, 2022
Pharmacy Attys Risking Opioid MDL Sanctions, Judge Warns

Lawyers for CVS Pharmacy, Walgreens and Walmart will face discipline if they don't swiftly rectify noncompliance with a "clear and simple" directive to outline remedies after a jury blamed the companies for inundating communities with prescription narcotics, the top judge in multidistrict opioid litigation warned.
March 11, 2022
Key Opioid Cases To Watch As Massive Wave Of Trials Looms

Despite sweeping settlements and landmark verdicts, the nation's epic saga of opioid crisis litigation against Big Pharma is far from winding down, with the coming weeks heralding an unprecedented torrent of trials. Here, Law360 shares a detailed map of the opioid trials terrain and explores major lawsuits that are rapidly approaching moments of truth.
March 11, 2022
6th Circ. Orders Opioid MDL Judge To Unfreeze Cases

The Sixth Circuit on Friday ordered the Ohio federal judge overseeing opioid multidistrict litigation to rule on remand motions from three Texas counties and two New Mexico cities, finding that the cases have been pending for an "unduly long time."

← Previous
…
9
10
11
12
13
14
15
16
17
…
Next →